title: In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters.
abstract: Three low-molecular weight polyesters, poly(L-lactic acid) (PLA), copoly(lactic acid/glycolic acid) (PLGA) and poly(delta-valerolactone) (PV), were used to prepare water-soluble sodium diclofenac-loaded microspheres by using the oil-in-oil (o/o) emulsification-solvent evaporation method. Their micromeritic and physicochemical properties, and degradation and dissolution behaviours were determined in vitro. The results indicate that high encapsulation efficiency and better monodispersity might be achieved by the o/o emulsification-solvent evaporation method, depending on the amount of drug loading used. The slower evaporation of organic solvent from the system during microencapsulation seemed to modify the crystallinity of drug and polyester in the microspheres, determined by powder x-ray diffractometry and differential scanning calorimetry. The in vitro degradation rate of all the microspheres in pH7.4 phosphate buffer solution showed first-order kinetics and ranked in the order of PLGA > PLA > PV microspheres. Furthermore, the first-order release rate was also found in all the microspheres after an initial drug burst and ranked in the order of PLGA> PLA > PV microspheres, too. The relationship between degradation and dissolution behaviours of these microspheres is discussed.
authors.affiliation: Department of Medical Research and Education, Veterans General Hospital-Taipei, Taiwan, Republic of China. sylin@vghtpe.gov.tw
authors.forename: S Y
authors.initials: SY
authors.lastname: Lin
authors.forename: K S
authors.initials: KS
authors.lastname: Chen
authors.forename: H H
authors.initials: HH
authors.lastname: Teng
authors.forename: M J
authors.initials: MJ
authors.lastname: Li
mesh_terms: D001673:Biodegradation, Environmental; D002214:Capsules / Q000302:isolation & purification*; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D003692:Delayed-Action Preparations; D004008:Diclofenac / Q000008:administration & dosage; D004339:Drug Compounding / Q000379:methods*; D066298:In Vitro Techniques; D019344:Lactic Acid; D008863:Microspheres; D008970:Molecular Weight; D011091:Polyesters; D011100:Polyglycolic Acid; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers; D011753:Pyrones
chemical_list: D002214:Capsules; D003692:Delayed-Action Preparations; D011091:Polyesters; D011108:Polymers; D011753:Pyrones; D004008:Diclofenac; C052207:delta-valerolactone; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid; C033616:poly(lactide)